News & Updates
OptiRTP Selected to Present at 2026 SelectUSA Investment Summit
OptiRTP Limited has been selected to present in the Defense Pitching Session at the 2026 SelectUSA Investment Summit, engaging with investors, government representatives, and industry leaders from across the United States and international markets.
OptiRTP COO Sharyn Harper Joins New Zealand Delegation at 2026 SelectUSA Investment Summit
OptiRTP will attend the 2026 SelectUSA Investment Summit, May 3–6, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
OptiRTP Attends “Unlocking Business Potential with Japan” Seminar in Auckland
OptiRTP CEO Jon Doherty and Partnerships and Performance Manager Byron Thomas attended the Unlocking Business Potential with Japan seminar in Auckland, engaging with leaders across government, investment and business focused on strengthening New Zealand–Japan economic ties.
OptiRTP Attends AmCham “Doing Business in the USA” Workshop as Part of U.S. Expansion Preparation
OptiRTP attended the annual “Doing Business in the USA” workshop hosted by AmCham New Zealand, with sponsorship from EMA, ExportNZ and Norris Echetebu Law.
OptiRTP Briefs U.S. Consulate and Commercial Service on U.S. Market Strategy
OptiRTP CEO Jon Doherty and Founder & CTO Bogdan Anich met with the United States Consulate General and the U.S. Commercial Service in Auckland on 4 March to discuss the company’s United States market strategy.
OptiRTP Deepens Engagement with Evidence-Based Oncology Research Community
OptiRTP Limited is pleased to announce that Sharyn Harper, Chief Operating Officer, has joined the Society for Integrative Oncology (SIO) as a member, with a particular focus on the organisation’s Research Committee.
OptiRTP CEO Attends AUT Future of Health Conference
OptiRTP CEO Jon Doherty attended AUT’s Future of Health: Where Aotearoa Leads Next conference, joining leaders from across New Zealand’s health system to discuss the next phase of healthcare innovation.
OptiRTP Attends U.S. Consulate Reception Welcoming U.S. SailGP Team
OptiRTP CEO Jon Doherty and Partnerships & Performance Manager Byron Thomas attended a reception on 13 February hosted by U.S. Consul General Melissa Sweeney to welcome the U.S. SailGP Team to Auckland for the second leg of the SailGP 2026 championship.
OptiRTP Schedules Meetings with Two Pharmaceutical Companies to Discuss Co-Therapy Applications
OptiRTP has scheduled meetings with two established New Zealand pharmaceutical companies in January 2026 to discuss potential co-therapy applications for its Optimum Bio Sound Therapy (OBST) neuromodulation platform.
OptiRTP meets New Zealand’s Ambassador-Designate to the United States
OptiRTP CEO Jon Doherty and Founder & CTO Bogdan Anich attended a networking function with Chris Seed, New Zealand’s Ambassador-Designate to the United States, on 4 December 2025.
OptiRTP Presents to S&C Practitioners at Inaugural NZSCA-SPRINZ Conference
OptiRTP presented its Optimum Bio Sound Therapy (OBST) platform to approximately 50–60 strength and conditioning coaches, sport scientists, medical professionals, and academics at the inaugural NZSCA-SPRINZ Strength & Conditioning Practitioners Day on 18 November 2025.
OptiRTP Presents U.S. Expansion Strategy to 40+ Investors at Auckland Briefing
OptiRTP presented its U.S. market entry strategy and clinical validation roadmap to more than 40 current and prospective investors at a private briefing held at Buddle Findlay’s Auckland office on 6 November 2025.
OptiRTP Attends Nisuikai Event on Japan–New Zealand Economic Diplomacy
OptiRTP CEO Jon Doherty attended the Japanese Chamber of Commerce of Auckland (Nisuikai) seminar on 21 October 2025, as the company continues building connections ahead of its planned Japan market entry from 2027.
OptiRTP Presents to Utah Governor’s Delegation at AmCham Briefing
OptiRTP CEO Jon Doherty presented the company’s Optimum Bio Sound Therapy platform to a Utah state delegation led by Governor Spencer J. Cox at an AmCham business briefing held during Auckland Start-Up Week on 20 October 2025.
AmCham NZ Profiles OptiRTP as MedTech Export Case Study
The American Chamber of Commerce in New Zealand (AmCham) has published a feature on OptiRTP, profiling the company’s Optimum Bio Sound Therapy platform as an example of New Zealand medical technology expanding into international markets.
OptiRTP Joins Japan New Zealand Business Council
OptiRTP has joined the Japan New Zealand Business Council (JNZBC), a network of New Zealand and Japanese organisations focused on bilateral trade and business relationships.
